Amicus Therapeutics, Inc.
FOLDDelisted Apr 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178879
Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Amicus Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 213 | 3 | 222 | +12 |
| Shares | 305.2M | 10.5K | 292.4M | −12.8M (−4.2%) |
| Value | $3.28B | $113.0K | $3.05B | −$229.0M (−7.0%) |
3 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (34)
Institutions that held Amicus Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (22)
Institutions that held Amicus Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 848,157 | $9.11M |
| Sphera Funds Management Ltd. | 753,037 | $8.09M |
| Eversept Partners, LP | 478,245 | $5.14M |
| Connor, Clark & Lunn Investment Management Ltd. | 110,652 | $1.19M |
| Jennison Associates LLC | 65,788 | $707.0K |
| American Century Companies Inc | 49,340 | $530.0K |
| Voloridge Investment Management, LLC | 47,952 | $515.0K |
| Schonfeld Strategic Advisors LLC | 34,639 | $372.0K |
| Guggenheim Capital LLC | 32,199 | $346.0K |
| Trexquant Investment LP | 27,077 | $291.0K |
| Gyon Technologies Capital Management, LP | 26,399 | $284.0K |
| Squarepoint Ops LLC | 12,500 | $134.0K |
| Gsa Capital Partners LLP | 12,023 | $129.0K |
| Gotham Asset Management, LLC | 11,561 | $124.0K |
| Patriot Financial Group Insurance Agency, LLC | 1,205 | $13.0K |
| Antonetti Capital Management LLC | 900 | $10.0K |
| Captrust Financial Advisors | 248 | $3.00K |
| Moisand Fitzgerald Tamayo, LLC | 100 | $1.00K |
| FourThought Financial, LLC | 118 | $1.00K |
| Canada Pension Plan Investment Board | 10 | $0 |
| Quadrant Capital Group LLC | 28 | $0 |
| International Biotechnology Trust PLC | 1,017 | – |
Not filed for Q3 2022 yet (3)
Institutions that held Amicus Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Fieldpoint Private Securities, LLC | 10,241 | $110.0K |
| Cordasco Financial Network | 140 | $2.00K |
| Exane Derivatives | 90 | $966 |